Key result
Subadventitial stenting for in-stent chronic total occlusions had a 24-month target-vessel failure rate of 13.8%, similar to historical controls treated with within-stent stenting (19.5%, P=0.49).
Why the study?
Does subadventitial stenting improve target-vessel failure compared to within-stent stenting in patients with in-stent chronic total occlusions?
Cohort (n=422)
Yes
Does subadventitial stenting improve target-vessel failure compared to within-stent stenting in patients with in-stent chronic total occlusions?
Absolute Event Rate: 13.8% vs 19.5%
p-value: p=0.49
Subadventitial stenting is a feasible bailout technique for complex in-stent chronic total occlusions, demonstrating mid-term target-vessel failure rates comparable to conventional within-stent stenting.
SS for IS-CTO may be feasible per registry data; leaves open whether it reduces TVF versus WSS in RCTs.
OBJECTIVES: To evaluate the outcomes of subadventitial stenting (SS) around occluded stents for recanalizing in-stent chronic total occlusions (IS-CTOs). BACKGROUND: There is little evidence on the outcomes of SS for IS-CTO. METHODS: We examined the outcomes of SS for IS-CTO PCI at 14 centers between July 2011 and June 2017, and compared them to historical controls recanalized using within-stent stenting (WSS). Target-vessel failure (TVF) on follow-up was the endpoint of this study, and was defined as a composite of cardiac death, target-vessel myocardial infarction, and target-vessel revascularization. RESULTS: During study period, 422 IS-CTO PCIs were performed, of which 32 (7.6%) were recanalized with SS, usually when conventional approaches failed. The most frequent CTO vessel was the right coronary artery (72%). Mean J-CTO score was 3.1 ± 0.9. SS was antegrade in 53%, and retrograde in 47%. Part of the occluded stent was crushed in 37%, while the whole stent was crushed in 63%. Intravascular imaging was used in 59%. One patient (3.1%) suffered tamponade. Angiographic follow-up was performed in 10/32 patients: stents were patent in six cases, one had mild neointimal hyperplasia, and three had severe restenosis at the SS site. Clinical follow-up was available for 29/32 patients for a mean of 388 ± 303 days. The 24-month incidence of TVF was 13.8%, which was similar to historical controls treated with WSS (19.5%, P = 0.49). CONCLUSIONS: SS is rarely performed, usually as last resort, to recanalize complex IS-CTOs. It is associated with favorable acute and mid-term outcomes, but given the small sample size of our study additional research is warranted.
No takes yet. Share an insight, caveat, or question.
Azzalini et al. (2018) conducted a cohort in In-stent chronic total occlusions (IS-CTOs) (n=422). Subadventitial stenting (SS) vs. Historical controls recanalized using within-stent stenting (WSS) was evaluated on Target-vessel failure (composite of cardiac death, target-vessel myocardial infarction, and target-vessel revascularization) (p=0.49). Subadventitial stenting for in-stent chronic total occlusions had a 24-month target-vessel failure rate of 13.8%, similar to historical controls treated with within-stent stenting (19.5%, P=0.49).
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: